NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Jamil was not in the P3 trial. I think you’re right and that he was one of the patients treated in one of the earlier UCLA trials.

Sentiment,

I think Jamil is in this ongoing Phase III DCVax-L trial. He says he was joining a three-year clinical trial with DCVax-L, a vaccine that utilizes a patient’s individual tumor cells to stimulate the patient’s own immune system.

It has been quite a journey for Jamil, a long-time Laker fan who lives in Hawaii and travels frequently to receive care at UCLA. He started experiencing headaches and nausea in May 2012. He went to the emergency room and doctors diagnosed him with a glioblastoma multiforme brain tumor, telling him he might have little time left to live.

Jamil received radiation treatment for three months and chemotherapy for a year before undergoing successful surgery at the hands of Dr. Linda M. Liau at UCLA. "After the brain tumor surgery when I saw my MRI, my family and I were very relieved, kind of joy and hope at the same time," Jamil say.

https://www.uclahealth.org/lakers/jamil-newirth

Newirth was diagnosed with a fast-growing brain cancer called Glioblastoma in 2012. He underwent delicate brain surgery performed by Dr. Liau at UCLA, and then radiation and chemotherapy, before joining a three-year clinical trial with DCVax-L, a vaccine that utilizes a patient’s individual tumor cells to stimulate the patient’s own immune system.

Even though the tumor is now almost gone, Newirth checks in every two or three months with Dr. Liau who is interim chair of the Neurosurgery Department at UCLA’s Jonsson Comprehensive Cancer Center. Dr. Liau’s vaccine discovery is now being offered at 50 sites across the country, says Newirth.

But Newirth says he never would have found out about the life-saving clinical trial with Dr. Liau if not for the research skill he learned at UH Law School.

“There are thousands and thousands of clinical trials, and it helped me narrow down to the best trials for me, and then focus on the key factors that would benefit my condition the most,” he says.

https://www.law.hawaii.edu/article/jamil-newirth-12-i-feel-lucky-says-uh-law-school-grad-and-cancer-survivor-who-laker-day

Newirth began a clinical trial at the University of California Los Angeles where he met Dr. Linda Liau, a professor of neurosurgery and director of the UCLA Brain Tumor Program.

"His story was just so compelling that I felt that we should do what we can to get him on the trial," said Liau, in a video provided by Newirth.
The experimental treatment included surgery, radiation, and a year of chemotherapy.

Newirth said he still has a remaining tumor but shows no signs of regrowth that is closely monitored at UCLA.

https://www.hawaiinewsnow.com/story/35562012/a-maui-lawyer-with-brain-cancer-was-given-17-months-to-live-that-was-5-years-ago/